Skip to content
Disclosery

China Universal Asset Management Co., Ltd.

Follow

13F filer, CIK 1906594, SHANGHAI, China

China Universal Asset Management Co., Ltd. reported $1,672,171,417 across 513 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-07-24. Its ten largest share positions make up 34.79% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001906594-26-000003

Period
2026-06-30
Reported value
$1.67B
Holdings
513
Top 10 weight
34.79%
New
48
Sold out
37

Largest buys vs the previous quarter

SecurityShares changeApprox. value
KLACadded+61,438$18.5M
SNDKadded+5,108$11.6M
AMZNadded+46,827$11.2M
NVDAadded+42,355$8.47M
AAPLadded+28,890$8.36M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
IAUreduced-96,000-$7.25M
GLDreduced-17,450-$6.43M
GLDMreduced-77,000-$6.12M
AZNexited-25,600-$5.05M
HONexited-17,882-$4.04M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001906594-26-000003, largest first. % of portfolio is the value over $1,672,171,417, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RANIRANI THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 15,894 shares; 2026Q1: 17,311 shares; 2026Q2: 17,887 shares 17,887$13.6K<0.01%+576Timeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100 shares 100$12.3K<0.01%newTimeline
GSKGSK PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 54,345 shares; 2024Q4: 338 shares; 2025Q1: 338 shares; 2025Q2: 338 shares; 2025Q3: 6,000 shares; 2025Q4: 0 shares; 2026Q1: 16,000 shares; 2026Q2: 0 shares 0$9.07K<0.01%-16,000Amount filed as zero, left out of ratios.Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 1,574 shares; 2025Q1: 1,574 shares; 2025Q2: 1,574 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 200 shares 200$8.92K<0.01%newTimeline
TNDMTANDEM DIABETES CARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 8,000 shares; 2025Q4: 8,000 shares; 2026Q1: 5,000 shares; 2026Q2: 500 shares 500$7.54K<0.01%-4,500Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 18,718 shares; 2024Q4: 20,765 shares; 2025Q1: 19,875 shares; 2025Q2: 20,083 shares; 2025Q3: 17,741 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,600 shares 3,600$7.24K<0.01%newTimeline
TMDXTRANSMEDICS GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,000 shares; 2025Q4: 1,000 shares; 2026Q1: 1,000 shares; 2026Q2: 100 shares 100$6.64K<0.01%-900Timeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 47,716 shares; 2026Q1: 41,074 shares; 2026Q2: 37,352 shares 37,352$6.15K<0.01%-3,722Timeline
TMETENCENT MUSIC ENTMT GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 85,000 shares; 2025Q3: 98,000 shares; 2025Q4: 92,100 shares; 2026Q1: 500 shares; 2026Q2: 500 shares 500$4.17K<0.01%0Timeline
CAMPCAMP4 THERAPEUTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,000 shares; 2026Q1: 16,000 shares; 2026Q2: 800 shares 800$3.5K<0.01%-15,200Timeline
PBRPETROLEO BRASILEIRO S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 120,200 shares; 2026Q2: 0 shares 0$2.43K<0.01%-120,200Amount filed as zero, left out of ratios.Timeline
CMGCHIPOTLE MEXICAN GRILL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 68,353 shares; 2024Q4: 58,305 shares; 2025Q1: 11,661 shares; 2025Q2: 20,961 shares; 2025Q3: 61 shares; 2025Q4: 61 shares; 2026Q1: 61 shares; 2026Q2: 61 shares 61$2.07K<0.01%0Timeline
HSYHERSHEY COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 10 shares; 2024Q4: 10 shares; 2025Q1: 10 shares; 2025Q2: 10 shares; 2025Q3: 10 shares; 2025Q4: 10 shares; 2026Q1: 10 shares; 2026Q2: 10 shares 10$1.75K<0.01%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AZNASTRAZENECA PLC25,600$5.05Mshares
HONHONEYWELL INTL INC17,882$4.04Mshares
ASNDASCENDIS PHARMA A/S10,925$2.5Mshares
FUTUFUTU HLDGS LTD10,800$1.48Mshares
RIGTRANSOCEAN LTD221,900$1.47Mshares
RDDTREDDIT INC9,600$1.29Mshares
ACLXARCELLX INC10,378$1.19Mshares
SPOTSPOTIFY TECHNOLOGY S A2,450$1.19Mshares
TRITHOMSON REUTERS CORP12,514$1.13Mshares
SESEA LTD13,421$1.11Mshares
TERNTERNS PHARMACEUTICALS INC18,869$995Kshares
ABTABBOTT LABORATORIES9,518$977Kshares
ZSZSCALER INC6,723$943Kshares
APLSAPELLIS PHARMACEUTICALS INC22,684$913Kshares
CNTACENTESSA PHARMACEUTICALS PLC21,225$843Kshares
CTSHCOGNIZANT TECHNOLOGY SOLUTIO13,453$825Kshares
CHTRCHARTER COMMUNICATIONS INC3,562$769Kshares
VRSKVERISK ANALYTICS INC3,880$736Kshares
JOYYJOYY INC12,000$701Kshares
MDTMEDTRONIC PLC6,789$592Kshares
RMBSRAMBUS INC DEL6,000$516Kshares
CSGPCOSTAR GROUP INC11,809$476Kshares
DAWNDAY ONE BIOPHARMACEUTICALS I18,331$393Kshares
HSAIHESAI GROUP20,000$382Kshares
NVONOVO-NORDISK A S8,100$305Kshares
SNOWSNOWFLAKE INC2,000$302Kshares
IQVIQVIA HLDGS INC1,600$273Kshares
ALVAUTOLIV INC2,000$210Kshares
KALVKALVISTA PHARMACEUTICALS INC8,970$181Kshares
EVMNEVOMMUNE INC5,000$115Kshares
LILI AUTO INC5,000$89.2Kshares
SIVRABRDN SILVER ETF TRUST1,000$71.6Kshares
SLVISHARES SILVER TR1,000$68.1Kshares
VALNVALNEVA SE5,000$31.2Kshares
CSIQCANADIAN SOLAR INC2,000$27.7Kshares
NKENIKE INC350$18.6Kshares
CCRNCROSS CTRY HEALTHCARE INC1,600$15Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001906594-26-000003 base2026-07-24acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001906594-26-000003 Quarter ended 2026-06-302026-07-24acceptance time not in the bulk data set
13F-HR 0001906594-26-000002 Quarter ended 2026-03-312026-04-28acceptance time not in the bulk data set
13F-HR 0001906594-26-000001 Quarter ended 2025-12-312026-01-29acceptance time not in the bulk data set
13F-HR 0001906594-25-000006 Quarter ended 2025-09-302025-11-10acceptance time not in the bulk data set
13F-HR 0001906594-25-000003 Quarter ended 2025-06-302025-08-28acceptance time not in the bulk data set
13F-HR 0001906594-25-000002 Quarter ended 2025-03-312025-04-30acceptance time not in the bulk data set
13F-HR 0001906594-25-000001 Quarter ended 2024-12-312025-01-24acceptance time not in the bulk data set
13F-HR 0001906594-24-000011 Quarter ended 2024-09-302024-10-25acceptance time not in the bulk data set
13F-HR 0001906594-24-000009 Quarter ended 2024-06-302024-07-19acceptance time not in the bulk data set
13F-HR/A 0001906594-24-000004 Quarter ended 2022-12-312024-05-22acceptance time not in the bulk data set
13F-HR/A 0001906594-24-000006 Quarter ended 2023-06-302024-05-22acceptance time not in the bulk data set
13F-HR/A 0001906594-24-000005 Quarter ended 2023-03-312024-05-22acceptance time not in the bulk data set
13F-HR/A 0001906594-24-000008 Quarter ended 2023-12-312024-05-22acceptance time not in the bulk data set
13F-HR/A 0001906594-24-000007 Quarter ended 2023-09-302024-05-22acceptance time not in the bulk data set
13F-HR/A 0001906594-24-000003 Quarter ended 2024-03-312024-05-21acceptance time not in the bulk data set
13F-HR 0001906594-24-000002 Quarter ended 2024-03-312024-04-29acceptance time not in the bulk data set
13F-HR 0001906594-24-000001 Quarter ended 2023-12-312024-01-24acceptance time not in the bulk data set
13F-HR 0001906594-23-000005 Quarter ended 2023-09-302023-10-31acceptance time not in the bulk data set
13F-HR 0001906594-23-000004 Quarter ended 2023-06-302023-07-28acceptance time not in the bulk data set
13F-HR 0001906594-23-000003 Quarter ended 2023-03-312023-04-28acceptance time not in the bulk data set
13F-HR 0001906594-23-000002 Quarter ended 2022-12-312023-01-31acceptance time not in the bulk data set
13F-HR 0001906594-22-000007 Quarter ended 2022-09-302022-10-21acceptance time not in the bulk data set
13F-HR 0001906594-22-000006 Quarter ended 2022-06-302022-08-12acceptance time not in the bulk data set
13F-HR 0001906594-22-000005 Quarter ended 2022-03-312022-04-25acceptance time not in the bulk data set
13F-HR 0001906594-22-000003 Quarter ended 2021-12-312022-02-11acceptance time not in the bulk data set